NewAmsterdam Pharma (NAMS) SEC Filings & 10K Form

$21.45
+1.22 (+6.03%)
(As of 04/23/2024 ET)

Recent NewAmsterdam Pharma SEC Filings

DateFilerForm TypeView
04/19/2024
3:21 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B3
04/17/2024
11:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form EFFECT
04/12/2024
3:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form POS AM
04/12/2024
3:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form POS AM
04/01/2024
7:16 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:30 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
3:30 PM
Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
4:37 PM
Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2024
3:18 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B3
03/10/2024
11:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form EFFECT
03/04/2024
7:06 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
7:00 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2024
7:11 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
10:11 AM
Frazier Life Sciences X, L.P. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13D/A
02/15/2024
3:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B5
02/15/2024
3:18 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
4:00 PM
LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3/A
01/25/2024
4:00 PM
Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3/A
01/22/2024
7:01 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
6:43 PM
Lewis William (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:40 PM
Lewis William (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2024
7:21 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
7:08 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
4:26 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:17 PM
Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:17 PM
LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:19 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
van der Kamp Hilde Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:21 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:10 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:13 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Smither John W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:14 PM
Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:04 PM
Downing Nicholas (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
4:09 PM
Bain Capital Life Sciences Fund II, L.P. (Reporting)
Bain Capital Life Sciences Fund III, L.P. (Reporting)
Bain Capital Life Sciences III General Partner, LLC (Reporting)
Bain Capital Life Sciences Investors II, LLC (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
BCIP Life Sciences Associates, LP (Reporting)
BCLS Fund III Investments GP, LLC (Reporting)
BCLS Fund III Investments, LP (Reporting)
BCLS II Investco , LLC (0001819101) (Reporting)
BCLS II Investco, LP (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
van der Kamp Hilde Johanna (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Slootweg Hugo Alexander (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
Exposed: 10 CENT Crypto to Explode April 20th? (Ad)

The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…

Click For My #1 FREE Crypto for 2024
12/29/2023
3:30 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Smither John W (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/19/2023
11:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form EFFECT
12/19/2023
3:36 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B3
11/13/2023
7:22 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2023
7:24 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B3
10/23/2023
7:12 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2023
7:10 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/21/2023
6:14 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/21/2023
6:18 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B3
09/19/2023
8:30 PM
Morningside Venture Investments Ltd (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13G/A
08/15/2023
3:52 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B3
08/14/2023
3:52 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2023
11:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form EFFECT
08/07/2023
6:56 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form POS AM
08/07/2023
6:24 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2023
6:38 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2023
3:30 PM
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
07/07/2023
4:00 PM
Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13D
07/07/2023
4:06 PM
Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13D/A
06/21/2023
3:01 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2023
3:04 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B3
06/20/2023
3:30 PM
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G
06/13/2023
4:04 PM
BCLS II Investco, LP (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13D/A
06/09/2023
8:39 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/09/2023
8:43 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B3
06/09/2023
2:47 PM
Frazier Life Sciences X, L.P. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13D/A
06/05/2023
7:50 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/31/2023
7:00 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2023
7:11 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2023
7:14 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B3
05/08/2023
7:33 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B3
05/08/2023
7:30 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2023
7:14 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B3
04/24/2023
11:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form EFFECT
04/24/2023
7:08 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:NAMS) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners